The object of this work was to study the pharmacokinetic differences and th
e cause of these differences in cirrhotic rats induced by biliary obstructi
on when aminophylline (8 mg/kg as theophylline, i.v.) was administered. The
concentrations of theophylline and its major metabolite (1,3-dimethyluric
acid) in plasma were determined by HPLC. In addition, formation of 1,3-dime
thyluric acid from theophylline in microsomes and the changes in the activi
ty of drug metabolizing enzymes, which are suggested to be involved in theo
phylline metabolism, were determined. In cirrhotic rats, the systemic clear
ance of theophylline was reduced to 30% of the control value while AUC (are
a under the plasma concentration-time curve) and (t(1/2))(beta) were increa
sed 1.3 fold and 3.5 fold, respectively. The formation of 1,3-dimethyluric
acid was decreased to 30% of the control value in microsomes of cirrhotic r
at liver. In cirrhotic rat liver, activities of aniline hydroxylase (CYP2E1
related), erythromycin-N-demethylase (CYP3A related), and methoxyresorufin
-O-demethylase (CYP1A2 related), which were reported to be related with the
ophylline metabolism, were decreased to 67%, 53%, and 76% that of normal ra
t liver, respectively. From the results, it can be concluded that in cirrho
tic rats induced by biliary obstruction, the total body clearance of theoph
ylline is markedly reduced and it may be due to decreased activity of drug
metabolizing enzymes in liver.